I-Bridge Capital, a healthcare-focused venture capital firm and incubator founded by an ex-partner of Kleiner Perkins Caufield & Byers (KPCB), has established a joint venture with Israeli drug company BioLineRx Ltd. to incubate innovative healthcare start-ups.
The joint venture, named iPharma, will seek to develop innovative clinical and pre-clinical therapeutic projects originating primarily in Israel to serve the Chinese and global healthcare markets.
Each partner is to provide seed capital of US$1 million to the venture.
"The market in China is large and fast-growing, but it lacks innovative therapeutic assets and capabilities which address the increasing demands of our rapidly aging population," says Dr. Jimmy Wei, managing partner and founder of I-Bridge Capital, previously at KPCB for four years, in Continue Reading the Entire Article Here >>
